HUP9603364A2 - Pharmaceutical composition containing ipriflavone being useful for bone deficiency and process for producing it - Google Patents

Pharmaceutical composition containing ipriflavone being useful for bone deficiency and process for producing it

Info

Publication number
HUP9603364A2
HUP9603364A2 HU9603364A HUP9603364A HUP9603364A2 HU P9603364 A2 HUP9603364 A2 HU P9603364A2 HU 9603364 A HU9603364 A HU 9603364A HU P9603364 A HUP9603364 A HU P9603364A HU P9603364 A2 HUP9603364 A2 HU P9603364A2
Authority
HU
Hungary
Prior art keywords
useful
producing
pharmaceutical composition
composition containing
bone deficiency
Prior art date
Application number
HU9603364A
Other languages
Hungarian (hu)
Inventor
Tibor Horváth
Ferenc Lévai
Tibor Szabó
Szabó Katalin Urbán
Márta Venczel
Erzsébet Végeli
Original Assignee
Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. filed Critical Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt.
Priority to HU9603364A priority Critical patent/HUP9603364A2/en
Publication of HU9603364D0 publication Critical patent/HU9603364D0/en
Priority to PCT/HU1997/000079 priority patent/WO1998024419A1/en
Priority to AU54053/98A priority patent/AU5405398A/en
Publication of HUP9603364A2 publication Critical patent/HUP9603364A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya patőlógiásan keletkező vagy művi útőn kialakítőttcsőnthiány pótlására szőlgáló, 40-95 t% Ipriflavőnt tartalmazógranűlátűm, amely segédanyagként 5-60 t% Eűdragit RS PO-t éslágyítószert, előnyösen PEG 200-600-at tartalmaz, (1-2) : 1-(0,4-1): 1tömegarányban, 0-1,5 t% őldószer mellett. ŕThe subject of the invention is a granule containing 40-95 t% Ipriflavone, which is grown to compensate for pathologically or artificially formed cyst deficiency, which contains 5-60 t% Eűdragit RS PO and a plasticizer, preferably PEG 200-600, as excipients, (1-2) : 1 -(0.4-1): 1 in mass ratio, with 0-1.5 t% solvent. ŕ

HU9603364A 1996-12-06 1996-12-06 Pharmaceutical composition containing ipriflavone being useful for bone deficiency and process for producing it HUP9603364A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HU9603364A HUP9603364A2 (en) 1996-12-06 1996-12-06 Pharmaceutical composition containing ipriflavone being useful for bone deficiency and process for producing it
PCT/HU1997/000079 WO1998024419A1 (en) 1996-12-06 1997-12-02 Ipriflavone composition
AU54053/98A AU5405398A (en) 1996-12-06 1997-12-02 Ipriflavone composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9603364A HUP9603364A2 (en) 1996-12-06 1996-12-06 Pharmaceutical composition containing ipriflavone being useful for bone deficiency and process for producing it

Publications (2)

Publication Number Publication Date
HU9603364D0 HU9603364D0 (en) 1997-01-28
HUP9603364A2 true HUP9603364A2 (en) 1998-12-28

Family

ID=89994524

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603364A HUP9603364A2 (en) 1996-12-06 1996-12-06 Pharmaceutical composition containing ipriflavone being useful for bone deficiency and process for producing it

Country Status (3)

Country Link
AU (1) AU5405398A (en)
HU (1) HUP9603364A2 (en)
WO (1) WO1998024419A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020014570A (en) * 2000-08-18 2002-02-25 김충섭 Process for Preparing Amorphous-type Ipriflavone by Solid-Dispersion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201474B (en) * 1987-02-03 1990-11-28 Tibor Balogh Process for producing new dentriatrical composition
US5504105A (en) * 1990-03-23 1996-04-02 Chinoin Pharmaceutical And Chemical Works Co. Ltd. Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
IT1256386B (en) * 1992-11-13 1995-12-04 Luigi Boltri PHARMACEUTICAL COMPOSITIONS INCLUDING A DRUG, A CROSS-LINKED POLYMERIC SUBSTANCE, AN OIL AND A SURFACTIVE AGENT

Also Published As

Publication number Publication date
AU5405398A (en) 1998-06-29
HU9603364D0 (en) 1997-01-28
WO1998024419A1 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
ATE130604T1 (en) NEW ARYLETHYLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FI882390A0 (en) Tetrazoles, which are intermediates in antihypertensive compounds
ES2194987T3 (en) USEFUL TRICICLIC COMPOUNDS TO INHIBIT THE FARNESIL-PROTEIN-TRANSFERASA.
MD1838F2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
NO954320D0 (en) Lyospheres comprising gonadotropin
DK0564350T3 (en) 3,5-di-tert-butyl-4-hydroxy flavones, process for their preparation and pharmaceutical compositions having antioxidant and anti-vasoconstrictor action
AU3923789A (en) Diorganopolysiloxane derivatives, their preparation and their use
BG100661A (en) Aryl acetic acid derivatives
ATE165827T1 (en) PRODUCTION OF N-ACETYLNEURAMINE ACID DERIVATIVES
DE69627166D1 (en) METHOD FOR PRODUCING 2-CHLORINE-5-CHLOMETHYL-THIAZOLE DERIVATIVES
FI972434A0 (en) Pharmaceutical composition containing lamotrigine
DE59601683D1 (en) SULFAMATE DERIVATIVES OF 1,3,5 (10) -STRATRIA DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
DE69433012D1 (en) METHOD FOR PRODUCING ORAL DOSAGE FORMULATIONS CONTAINING DICLOFENAC
MX9708735A (en) Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them.
CA2047802A1 (en) Pharmaceutical compositions
HUP9603364A2 (en) Pharmaceutical composition containing ipriflavone being useful for bone deficiency and process for producing it
DE59712943D1 (en) PROCESS FOR PREPARING (S) - OR (R) -3,3,3-TRIFLUOR-2-HYDROXY-2-METHYLPROPIONE ACID
TW252979B (en)
HK1023346A1 (en) Novel substituted tetrahyropyridine derivatives, method of preparation and pharmaceutical compositions containing them
IL108856A0 (en) Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
ATE125874T1 (en) METHOD FOR PRODUCING SOLID LACTULOSE.
DE59404784D1 (en) NEW CARBONIC ACID ESTERS OF 2-AMINO-7- (1,3-DIHYDROXY-2-PROPOXYMETHYL) PURIN, THEIR PRODUCTION AND USE THEREOF
ATE299851T1 (en) METHOD FOR PRODUCING INTERMEDIATE PRODUCTS
DE69029708D1 (en) Process for the preparation of AZT (3'-azido-3'-deoxythymidine) and related compounds
BG90414A (en) 2-AZABICYCLO (2,2,1)-HEPT-5-EN-2-ACETIC ACID AND ITS DERIVATIVES, METHOD OF PREPARATION AND THEIR APPLICATION